Published in J Endocrinol Invest on September 07, 2016
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia (1985) 109.13
Adipose tissue as an endocrine organ. Mol Cell Endocrinol (2009) 5.20
Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol (2005) 3.15
Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci U S A (2005) 2.31
Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes (2007) 1.96
Criteria and classification of obesity in Japan and Asia-Oceania. World Rev Nutr Diet (2005) 1.51
White adipose tissue as endocrine organ and its role in obesity. Arch Med Res (2008) 1.42
Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochem Biophys Res Commun (2005) 1.30
Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus. Metabolism (2010) 1.21
Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. J Clin Endocrinol Metab (2007) 1.19
The role of fat cell derived peptides in age-related metabolic alterations. Mech Ageing Dev (2001) 1.15
The effect of aging on the chaperone concentrations in the hepatic, endoplasmic reticulum of male rats: the possible role of protein misfolding due to the loss of chaperones in the decline in physiological function seen with age. J Gerontol A Biol Sci Med Sci (2006) 1.13
Vaspin prevents TNF-α-induced intracellular adhesion molecule-1 via inhibiting reactive oxygen species-dependent NF-κB and PKCθ activation in cultured rat vascular smooth muscle cells. Pharmacol Res (2011) 1.08
Serum levels of vaspin and visfatin in patients with coronary artery disease-Kozani study. Clin Chim Acta (2010) 1.05
Central vaspin administration acutely reduces food intake and has sustained blood glucose-lowering effects. Diabetologia (2011) 1.02
Adipose endocrine function, insulin-like growth factor-1 axis, and exceptional survival beyond 100 years of age. J Gerontol A Biol Sci Med Sci (2008) 1.01
Effects of weight reduction on serum vaspin concentrations in obese subjects: modification by insulin resistance. Obesity (Silver Spring) (2010) 1.00
A novel adipocytokine, vaspin inhibits platelet-derived growth factor-BB-induced migration of vascular smooth muscle cells. Biochem Biophys Res Commun (2012) 0.99
Vaspin attenuates high glucose-induced vascular smooth muscle cells proliferation and chemokinesis by inhibiting the MAPK, PI3K/Akt, and NF-κB signaling pathways. Atherosclerosis (2013) 0.96
Vaspin and its correlation with insulin sensitivity indices in obese children. Diabetes Res Clin Pract (2009) 0.95
Serum vaspin levels in type 2 diabetic women in relation to microvascular complications. Eur J Endocrinol (2008) 0.94
Serum vaspin level in relation to postprandial plasma glucose concentration in subjects with diabetes. Chin Med J (Engl) (2009) 0.93
Vaspin increases nitric oxide bioavailability through the reduction of asymmetric dimethylarginine in vascular endothelial cells. PLoS One (2012) 0.93
Vaspin protects vascular endothelial cells against free fatty acid-induced apoptosis through a phosphatidylinositol 3-kinase/Akt pathway. Biochem Biophys Res Commun (2011) 0.93
Adipokines and aging. J Atheroscler Thromb (2011) 0.92
Visceral adipose tissue-derived serine proteinase inhibitor inhibits apoptosis of endothelial cells as a ligand for the cell-surface GRP78/voltage-dependent anion channel complex. Circ Res (2013) 0.92
Association between serum vaspin concentrations and visceral adipose tissue in Korean subjects. Metabolism (2010) 0.91
A novel adipocytokine, visceral adipose tissue-derived serine protease inhibitor (vaspin), and obesity. J Int Med Res (2008) 0.91
Vaspin plasma concentrations and mRNA expressions in patients with stable and unstable angina pectoris. Clin Chem Lab Med (2011) 0.89
Chemerin regulates proliferation and differentiation of myoblast cells via ERK1/2 and mTOR signaling pathways. Cytokine (2012) 0.88
The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome. Endocr J (2011) 0.86
Calorie control increased vaspin levels of serum and periepididymal adipose tissue in diet-induced obese rats in association with serum free fatty acid and tumor necrosis factor alpha. Chin Med J (Engl) (2010) 0.77